- 4 August 2023
- book chapter
- Published by Elsevier
- p. 323-325
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- Trends in the crossover of patients in phase III oncology clinical trials in the USAecancermedicalscience, 2020
- Osimertinib versus platinum–pemetrexed for patients with EGFR T790M advanced NSCLC and progression on a prior EGFR-tyrosine kinase inhibitor: AURA3 overall survival analysisAnnals of Oncology, 2020
- Meta-analyses involving cross-over trials: methodological issuesInternational Journal of Epidemiology, 2002